Pharmaceutical drugs in the treatment of STEMI

Ker, James A.

dc.contributor.author	Ker, James A.
dc.date.accessioned	2016-09-02T08:00:19Z
dc.date.available	2016-09-02T08:00:19Z
dc.date.issued	2016-08
dc.description.abstract	Our concept of ST-segment Elevated Myocardial Infarction (STEMI) refers to when coronary blood supply decreases abruptly after a thrombotic occlusion. The underlying mechanism leading to the thrombotic event is an unstable atherosclerotic plaque which ruptured (or cracked or eroded) exposing the content of the plaque to the blood initiating thrombogenesis.	en_ZA
dc.description.department	Internal Medicine	en_ZA
dc.description.librarian	am2016	en_ZA
dc.description.uri	http://www.specialistforum.co.za	en_ZA
dc.identifier.citation	Ker, J 2016, 'Pharmaceutical drugs in the treatment of STEMI', The Specialist Forum, vol. 16, no. 7, pp. 20.	en_ZA
dc.identifier.issn	2218-8282
dc.identifier.uri	http://hdl.handle.net/2263/56589
dc.language.iso	en	en_ZA
dc.publisher	New Media Publishing	en_ZA
dc.rights	© The Specialist Forum	en_ZA
dc.subject	Thrombotic occlusion	en_ZA
dc.subject	Unstable atherosclerotic plaque	en_ZA
dc.subject	Coronary blood supply	en_ZA
dc.subject	ST-segment Elevated Myocardial Infarction (STEMI)	en_ZA
dc.title	Pharmaceutical drugs in the treatment of STEMI	en_ZA
dc.type	Article	en_ZA